Found: 134
Select item for more details and to access through your institution.
Protocol digest of a randomized phase III trial comparing S-1-based chemoradiotherapy with/without nivolumab for unresectable locally advanced or borderline resectable pancreatic cancer: JCOG1908E (PENETRATE).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 11, p. 1214, doi. 10.1093/jjco/hyae084
- By:
- Publication type:
- Article
A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 926, doi. 10.1093/jjco/hyae056
- By:
- Publication type:
- Article
Transitional dynamics in oncology clinical trials: evaluating the impact of Clinical Trials Act on cooperative groups.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 7, p. 748, doi. 10.1093/jjco/hyae034
- By:
- Publication type:
- Article
Prognostic evaluation of the Ki-67 labeling system in histological grading of non-small round cell sarcoma: a supplementary analysis of a randomized controlled trial, JCOG1306.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 6, p. 675, doi. 10.1093/jjco/hyae020
- By:
- Publication type:
- Article
Protocol digest of a randomized controlled Phase III study comparing surgery alone versus adjuvant nivolumab versus adjuvant S-1 for locally advanced oesophageal squamous cell carcinoma with no pathological complete response after neoadjuvant chemotherapy followed by curative esophagectomy: Japan Clinical Oncology Group study JCOG2206 (SUNRISE Trial)
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 2, p. 212, doi. 10.1093/jjco/hyad150
- By:
- Publication type:
- Article
Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 2, p. 206, doi. 10.1093/jjco/hyad149
- By:
- Publication type:
- Article
A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 1, p. 103, doi. 10.1093/jjco/hyad137
- By:
- Publication type:
- Article
A multicenter randomized controlled trial of esophagectomy with or without prophylactic supraclavicular node dissection: a phase 3 trial (JCOG2013, MODERN3).
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 9, p. 858, doi. 10.1093/jjco/hyad071
- By:
- Publication type:
- Article
Protocol of a randomized phase II/III study of gemcitabine plus nab-paclitaxel combination therapy versus modified FOLFIRINOX versus S-IROX for metastatic or recurrent pancreatic cancer: JCOG1611 (GENERATE).
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 80, doi. 10.1093/jjco/hyac146
- By:
- Publication type:
- Article
Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 195, doi. 10.1093/jjco/hyad007
- By:
- Publication type:
- Article
Protocol digest of a phase III trial to evaluate the efficacy of preoperative chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with postoperative S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA Trial)
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 2, p. 168, doi. 10.1093/jjco/hyac154
- By:
- Publication type:
- Article
Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 4, p. 383, doi. 10.1093/jjco/hyab208
- By:
- Publication type:
- Article
Prospective evaluation of watchful waiting for early-stage lung cancer with ground-glass opacity: a single-arm confirmatory multicenter study: Japan Clinical Oncology Group study JCOG1906 (EVERGREEN study).
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1330, doi. 10.1093/jjco/hyab074
- By:
- Publication type:
- Article
A multi-institutional randomized phase III trial comparing postoperative radiotherapy to observation after adjuvant chemotherapy in patients with pathological N2 Stage III non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1916 (J-PORT study)
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 6, p. 999, doi. 10.1093/jjco/hyab037
- By:
- Publication type:
- Article
A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 836, doi. 10.1093/jjco/hyab025
- By:
- Publication type:
- Article
Prognostic impact of geriatric assessment in elderly patients with non-small cell lung cancer: an integrated analysis of two randomized phase III trials (JCOG1115-A).
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 685, doi. 10.1093/jjco/hyaa257
- By:
- Publication type:
- Article
Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A).
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 3, p. 498, doi. 10.1093/jjco/hyaa241
- By:
- Publication type:
- Article
Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG1702A.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 2, p. 185, doi. 10.1093/jjco/hyaa184
- By:
- Publication type:
- Article
Results from a 1-day workshop on the assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology Group and the European Organisation for Research and Treatment of Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 11, p. 1333, doi. 10.1093/jjco/hyaa119
- By:
- Publication type:
- Article
A multi-institutional randomized phase III trial comparing anatomical segmentectomy and wedge resection for clinical stage IA non-small cell lung cancer in high-risk operable patients: Japan Clinical Oncology Group Study JCOG1909 (ANSWER study).
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 10, p. 1209, doi. 10.1093/jjco/hyaa107
- By:
- Publication type:
- Article
A phase III randomized controlled trial comparing surgery plus adjuvant chemotherapy with preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for locally recurrent rectal cancer: Japan Clinical Oncology Group study JCOG1801 (RC-SURVIVE study)
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 8, p. 953, doi. 10.1093/jjco/hyaa058
- By:
- Publication type:
- Article
Study risk assessment of Japan Clinical Oncology Group (JCOG) clinical trials using the European Organisation for Research and Treatment of Cancer (EORTC) study risk calculator.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 727, doi. 10.1093/jjco/hyz050
- By:
- Publication type:
- Article
Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial).
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 10, p. 985, doi. 10.1093/jjco/hyz106
- By:
- Publication type:
- Article
Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policy.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 10, p. 901, doi. 10.1093/jjco/hyz093
- By:
- Publication type:
- Article
A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 4, p. 379, doi. 10.1093/jjco/hyz004
- By:
- Publication type:
- Article
Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND).
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 12, p. 1105, doi. 10.1093/jjco/hyy125
- By:
- Publication type:
- Article
Responding to the challenges of international collaborations between the east and the west – report of the first JCOG–EORTC symposium and a perspective from young JCOG and EORTC investigators.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 96, doi. 10.1093/jjco/hyy155
- By:
- Publication type:
- Article
Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 10, p. 950, doi. 10.1093/jjco/hyy114
- By:
- Publication type:
- Article
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT).
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 392, doi. 10.1093/jjco/hyy004
- By:
- Publication type:
- Article
Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3).
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 10, p. 986, doi. 10.1093/jjco/hyx108
- By:
- Publication type:
- Article
Collaboration between EORTC and JCOG--how to accelerate global clinical research partnership.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 2, p. 164, doi. 10.1093/jjco/hyw159
- By:
- Publication type:
- Article
Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT).
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 4, p. 385, doi. 10.1093/jjco/hyv213
- By:
- Publication type:
- Article
Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A).
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 8, p. 748, doi. 10.1093/jjco/hyw058
- By:
- Publication type:
- Article
Inter-institutional survival heterogeneity in chemoradiation therapy for esophageal cancer: exploratory analysis of the JCOG0303 study.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 4, p. 389, doi. 10.1093/jjco/hyv211
- By:
- Publication type:
- Article
A Phase III study of oral steroid administration versus local steroid injection therapy for the prevention of esophageal stricture after endoscopic submucosal dissection (JCOG1217, Steroid EESD P3).
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 11, p. 1087, doi. 10.1093/jjco/hyv120
- By:
- Publication type:
- Article
Intensive vs. Standard Post-Operative Surveillance in High-Risk Breast Cancer Patients (INSPIRE): Japan Clinical Oncology Group Study JCOG1204.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 10, p. 983, doi. 10.1093/jjco/hyv110
- By:
- Publication type:
- Article
A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study).
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 5, p. 494, doi. 10.1093/jjco/hyv012
- By:
- Publication type:
- Article
Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304).
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 6, p. 555, doi. 10.1093/jjco/hyv042
- By:
- Publication type:
- Article
A randomized controlled Phase II/III study comparing endoscopic balloon dilation combined with steroid injection versus radial incision and cutting combined with steroid injection for refractory anastomotic stricture after esophagectomy: Japan Clinical Oncology Group Study JCOG1207.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 4, p. 385, doi. 10.1093/jjco/hyv006
- By:
- Publication type:
- Article
Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC).
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 1, p. 119, doi. 10.1093/jjco/hyu169
- By:
- Publication type:
- Article
Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101).
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 1, p. 123, doi. 10.1093/jjco/hyu168
- By:
- Publication type:
- Article
Randomized Phase II/III Trial of Post-operative Chemoradiotherapy Comparing 3-Weekly Cisplatin with Weekly Cisplatin in High-risk Patients with Squamous Cell Carcinoma of Head and Neck: Japan Clinical Oncology Group Study (JCOG1008).
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 8, p. 770
- By:
- Publication type:
- Article
A Randomized Phase II/III Trial of Perioperative Chemotherapy with Adriamycin Plus Ifosfamide Versus Gemcitabine Plus Docetaxel for High-grade Soft Tissue Sarcoma: Japan Clinical Oncology Group Study JCOG1306.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 8, p. 765
- By:
- Publication type:
- Article
Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508
- Published in:
- International Journal of Hematology, 2012, v. 96, n. 1, p. 74, doi. 10.1007/s12185-012-1101-2
- By:
- Publication type:
- Article
Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305).
- Published in:
- 2010
- By:
- Publication type:
- journal article
A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part).
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 5, p. 4497, doi. 10.1007/s00520-022-06874-1
- By:
- Publication type:
- Article
Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512)
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 5, p. 2327, doi. 10.1007/s00520-020-05765-7
- By:
- Publication type:
- Article
Which is the Optimal Response Criteria for Evaluating Preoperative Treatment in Esophageal Cancer: RECIST or Histology?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 9, p. 3009, doi. 10.1245/s10434-013-2946-1
- By:
- Publication type:
- Article
The Role of Adjuvant Chemotherapy for Localized Squamous Cell Esophageal Cancer: Current Japanese Standard and the Unending Role of the Drawing Board.
- Published in:
- 2012
- By:
- Publication type:
- Editorial